CHORDATE MEDICAL HLG AB

CHORDATE MEDICAL HLG AB

Share · SE0009495559 · A2DJ60 (XSTO)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of CHORDATE MEDICAL HLG AB
No Price
Share Float & Liquidity
Free Float 67,68 %
Shares Float 1,83 M
Shares Outstanding 2,7 M
Company Profile for CHORDATE MEDICAL HLG AB Share
Chordate Medical Holding AB (publ), a medical technology company, develops products and solutions for the treatment of chronic migraine and rhinitis in Sweden. It focuses on the ear-nose and throat area. The company was founded in 2005 and is based in Kista, Sweden.

Company Data

Name CHORDATE MEDICAL HLG AB
Company Chordate Medical Holding AB (publ)
Website https://www.chordate.com
Primary Exchange XSTO Frankfurt
WKN A2DJ60
ISIN SE0009495559
Asset Class Share
Sector Healthcare
Industry Medical - Devices
CEO Anders Weilandt
Market Capitalization 11 Mio
Country Sweden
Currency EUR
Employees 0,0 T
Address KistagAngen 20B, 164 40 Kista
IPO Date 2022-02-15

Stock Splits

Date Split
29.08.2024 1:500
19.12.2022 1131:1000

Ticker Symbols

Name Symbol
NASDAQ STOCKHOLM AB CMH.ST
Frankfurt K1Z.F
More Shares
Investors who hold CHORDATE MEDICAL HLG AB also have the following shares in their portfolio:
Mortgage Oil Corp.
Mortgage Oil Corp. Share
PT Sillo Maritime Perdana Tbk
PT Sillo Maritime Perdana Tbk Share